A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet

This case report describes the clinical course of a heavily pretreated patient enrolled on the Phase II QUADRUPLE THREAT clinical trial (NCT02489903) with recurrent metastatic epithelial ovarian cancer that was previously treated with a platinum doublet and that benefited from another reintroduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Cottrill, Hope, Cason, Stephanie, Caroen, Scott, Oronsky, Bryan, Donaldson, Elvis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846910/
https://www.ncbi.nlm.nih.gov/pubmed/29552569
http://dx.doi.org/10.1177/2324709618760080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846910/
https://www.ncbi.nlm.nih.gov/pubmed/29552569
http://dx.doi.org/10.1177/2324709618760080

Ejemplares similares